Welcome to Markets Desk, let's get you caught up on what's moving.
Merck scored a significant regulatory win today as the FDA approved two formulations of KEYTRUDA, both in combination with Padcev, for muscle-invasive bladder cancer. That's a meaningful label expansion for one of oncology's top-earning franchises, reinforcing Merck's dominance in the immuno-oncology space and giving the stock a clear near-term catalyst.
Shifting to aviation, a Ryanair Boeing seven thirty seven Max diverted mid-flight after a cabin window dislodged between Greece and Germany, injuring at least one passenger. Reports suggest the passenger was partially drawn toward the opening. The incident puts Boeing back under scrutiny at a moment when the manufacturer has been working hard to rebuild its safety reputation with regulators and the flying public.
And on the consumer side, Disney's live-action Moana is off to a rough start, projecting somewhere between forty million and forty five million dollars in its opening weekend. For a studio banking on its remake pipeline to drive theatrical revenue, that's a softer landing than hoped, raising fresh questions about audience appetite for live-action adaptations of animated classics.
That's the tape. Markets Desk, signing off the floor.
